×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| DECIPHER LABS LIMITED | NA | NA | NA | NA | 11.4 | |
| Cian Healthcare Limited | NA | NA | NA | NA | 10.3 | |
| ADLINE CHEM LAB LIMITED | NA | NA | NA | NA | 10.2 |
DECIPHER LABS LIMITED, with Security Code 524752, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.0 | 0.1 | 0.0 | 0.0 | 0.2 | 3.4 | 0.4 | 0.1 | 0.2 | 0.2 |
| Expenses | 0.1 | 0.5 | 0.1 | 0.1 | 0.1 | 3.2 | 0.5 | 0.2 | 0.2 | 0.3 |
| Operating Profit | -0.1 | -0.3 | -0.1 | -0.1 | 0.1 | 0.1 | -0.1 | -0.1 | -0.1 | -0.1 |
| OPM % | -265.52% | -255.04% | 0% | 0% | 52.57% | 3.78% | -32.64% | -83.33% | -55.63% | -30.53% |
| Other Income | -2.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | -0.1 | -0.3 | -0.1 | -0.1 | 0.1 | 0.1 | -0.1 | -0.1 | -0.1 | -0.1 |
| Tax % | 0% | 7.7% | 16% | -16.7% | 0% | 2.3% | 4% | -1.7% | -1.1% | 0% |
| Net Profit | -2.3 | -0.4 | -0.1 | -0.1 | 0.1 | 0.1 | -0.1 | -0.1 | -0.1 | -0.2 |
| EPS in Rs | -2.3 | -0.36 | -0.12 | -0.07 | 0.09 | 0.13 | -0.13 | -0.06 | -0.09 | 0 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 11.1 | 9.8 | 9.5 | 7.5 | 8.3 | 10.6 | 7.4 | 5.9 | 5.8 | 3.5 |
| Expenses | 14.0 | 13.8 | 9.6 | 9.7 | 8.2 | 9.4 | 6.1 | 7.2 | 6.4 | 10.1 |
| Operating Profit | -3.0 | -4.0 | -0.1 | -2.2 | 0.1 | 1.2 | 1.3 | -1.3 | -0.6 | -6.6 |
| OPM % | -26.82% | -41.12% | -1.44% | -28.88% | 1.54% | 11.47% | 17.65% | -22.72% | -10.87% | -187.8% |
| Other Income | -4.6 | 0.2 | 0.0 | 0.1 | 0.0 | 0.3 | 0.2 | 0.1 | 0.2 | 0.9 |
| Interest | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Profit before tax | -5.5 | -4.1 | -0.2 | -2.1 | 0.0 | 1.2 | 1.4 | -1.3 | -0.6 | -5.8 |
| Tax % | 0.1% | 9.6% | 280.7% | -9.2% | -28.6% | 3.6% | -30.3% | 0.1% | 1.4% | 0% |
| Net Profit | -7.8 | -4.4 | -0.9 | -1.9 | 0.0 | 1.2 | 0.9 | -1.3 | -0.6 | -4.1 |
| EPS in Rs | -7.68 | -4.23 | -0.94 | -1.92 | 0.01 | 1.19 | 0.94 | -1.31 | -0.59 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 53% |
| 5 Years: | -12% |
| 3 Years: | 53% |
| TTM: | 1227% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | -45% |
| 3 Years: | -42% |
| TTM: | 68% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | -10% |
| 3 Years: | -39% |
| 1 Year: | -20% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 35% |
| 3 Years: | -14% |
| TTM: | -15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 103% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | -10% |
| 3 Years: | -39% |
| 1 Year: | -20% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|